NEJM:血流储备分数引导的PCI与冠状动脉搭桥手术的比较分析

2022-01-13 MedSci原创 MedSci原创

在三支冠状动脉疾病患者中,在1年时死亡、心肌梗死、卒中或重复血运重建的复合发生率方面,未发现FFR引导的PCI不劣于CABG。

已有研究发现三支冠状动脉疾病患者的冠状动脉旁路移植术(CABG)比经皮冠状动脉介入治疗(PCI)有更好的结局,但以血流储备分数(FFR)指标为指导的PCI效果如何一直尚未明确。

近日,顶级医学期刊NEJM上发表了一篇研究文章,在这项多中心、国际、非劣效性试验中,三支冠状动脉疾病患者被随机分配接受CABG或FFR引导的PCI,并使用当前一代佐他莫司洗脱支架。

该研究的主要终点是在1年内发生主要不良心脑血管事件,定义为全因死亡、心肌梗死卒中或重复血运重建。FFR引导的PCI与CABG的非劣效性被预先设定为风险比的95%置信区间的上限小于1.65。次要终点包括死亡、心肌梗死或卒中的复合终点;研究人员还评估了其安全性。

该研究共有1500名患者在48个中心接受了随机分组。接受PCI的患者平均植入了3.7±1.9个支架,接受CABG的患者接受了3.4±1.0处远端吻合。该研究的主要终点在随机分配接受FFR引导的PCI的患者中的1年发生率为10.6%,在分配接受CABG的患者中为6.9%(风险比为1.5;95%置信区间[CI]为1.1至2.2),FFR引导的PCI的结局非劣效性不一致(非劣效性P=0.35)。FFR引导的PCI组的死亡、心肌梗死或卒中发生率为7.3%,CABG组为5.2%(风险比为1.4;95%CI为0.9至2.1)。CABG组大出血、心律失常和急性肾损伤的发生率高于FFR引导的PCI组。

由此可见,在三支冠状动脉疾病患者中,在1年时死亡、心肌梗死、卒中或重复血运重建的复合发生率方面,未发现FFR引导的PCI不劣于CABG。

原始出处:
 
William F. Fearon,et al.Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery.NEJM.2021.https://www.nejm.org/doi/full/10.1056/NEJMoa2112299

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1663988, encodeId=d1fa1663988b9, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Sat Sep 24 08:52:33 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988407, encodeId=11ee198840ed3, content=<a href='/topic/show?id=18ae6365278' target=_blank style='color:#2F92EE;'>#比较分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63652, encryptionId=18ae6365278, topicName=比较分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Wed May 18 23:52:33 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194242, encodeId=b3fe1194242d7, content=<a href='/topic/show?id=36d313833c9' target=_blank style='color:#2F92EE;'>#PCI#</a><a href='/topic/show?id=77c33081e40' target=_blank style='color:#2F92EE;'>#冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13833, encryptionId=36d313833c9, topicName=PCI), TopicDto(id=30817, encryptionId=77c33081e40, topicName=冠心病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:57:15 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623534, encodeId=59b51623534dc, content=<a href='/topic/show?id=37de5691841' target=_blank style='color:#2F92EE;'>#搭桥手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56918, encryptionId=37de5691841, topicName=搭桥手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c320527759, createdName=stfoxst, createdTime=Fri Jan 14 23:52:33 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184021, encodeId=630b1184021ed, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8b5623723, createdName=ms6000000656440728, createdTime=Thu Jan 13 21:00:37 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183897, encodeId=d8e8118389e23, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a83e6464002, createdName=ms4000001897618690, createdTime=Thu Jan 13 15:22:13 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1663988, encodeId=d1fa1663988b9, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Sat Sep 24 08:52:33 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988407, encodeId=11ee198840ed3, content=<a href='/topic/show?id=18ae6365278' target=_blank style='color:#2F92EE;'>#比较分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63652, encryptionId=18ae6365278, topicName=比较分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Wed May 18 23:52:33 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194242, encodeId=b3fe1194242d7, content=<a href='/topic/show?id=36d313833c9' target=_blank style='color:#2F92EE;'>#PCI#</a><a href='/topic/show?id=77c33081e40' target=_blank style='color:#2F92EE;'>#冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13833, encryptionId=36d313833c9, topicName=PCI), TopicDto(id=30817, encryptionId=77c33081e40, topicName=冠心病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:57:15 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623534, encodeId=59b51623534dc, content=<a href='/topic/show?id=37de5691841' target=_blank style='color:#2F92EE;'>#搭桥手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56918, encryptionId=37de5691841, topicName=搭桥手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c320527759, createdName=stfoxst, createdTime=Fri Jan 14 23:52:33 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184021, encodeId=630b1184021ed, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8b5623723, createdName=ms6000000656440728, createdTime=Thu Jan 13 21:00:37 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183897, encodeId=d8e8118389e23, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a83e6464002, createdName=ms4000001897618690, createdTime=Thu Jan 13 15:22:13 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1663988, encodeId=d1fa1663988b9, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Sat Sep 24 08:52:33 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988407, encodeId=11ee198840ed3, content=<a href='/topic/show?id=18ae6365278' target=_blank style='color:#2F92EE;'>#比较分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63652, encryptionId=18ae6365278, topicName=比较分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Wed May 18 23:52:33 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194242, encodeId=b3fe1194242d7, content=<a href='/topic/show?id=36d313833c9' target=_blank style='color:#2F92EE;'>#PCI#</a><a href='/topic/show?id=77c33081e40' target=_blank style='color:#2F92EE;'>#冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13833, encryptionId=36d313833c9, topicName=PCI), TopicDto(id=30817, encryptionId=77c33081e40, topicName=冠心病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:57:15 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623534, encodeId=59b51623534dc, content=<a href='/topic/show?id=37de5691841' target=_blank style='color:#2F92EE;'>#搭桥手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56918, encryptionId=37de5691841, topicName=搭桥手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c320527759, createdName=stfoxst, createdTime=Fri Jan 14 23:52:33 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184021, encodeId=630b1184021ed, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8b5623723, createdName=ms6000000656440728, createdTime=Thu Jan 13 21:00:37 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183897, encodeId=d8e8118389e23, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a83e6464002, createdName=ms4000001897618690, createdTime=Thu Jan 13 15:22:13 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1663988, encodeId=d1fa1663988b9, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Sat Sep 24 08:52:33 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988407, encodeId=11ee198840ed3, content=<a href='/topic/show?id=18ae6365278' target=_blank style='color:#2F92EE;'>#比较分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63652, encryptionId=18ae6365278, topicName=比较分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Wed May 18 23:52:33 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194242, encodeId=b3fe1194242d7, content=<a href='/topic/show?id=36d313833c9' target=_blank style='color:#2F92EE;'>#PCI#</a><a href='/topic/show?id=77c33081e40' target=_blank style='color:#2F92EE;'>#冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13833, encryptionId=36d313833c9, topicName=PCI), TopicDto(id=30817, encryptionId=77c33081e40, topicName=冠心病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:57:15 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623534, encodeId=59b51623534dc, content=<a href='/topic/show?id=37de5691841' target=_blank style='color:#2F92EE;'>#搭桥手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56918, encryptionId=37de5691841, topicName=搭桥手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c320527759, createdName=stfoxst, createdTime=Fri Jan 14 23:52:33 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184021, encodeId=630b1184021ed, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8b5623723, createdName=ms6000000656440728, createdTime=Thu Jan 13 21:00:37 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183897, encodeId=d8e8118389e23, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a83e6464002, createdName=ms4000001897618690, createdTime=Thu Jan 13 15:22:13 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1663988, encodeId=d1fa1663988b9, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Sat Sep 24 08:52:33 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988407, encodeId=11ee198840ed3, content=<a href='/topic/show?id=18ae6365278' target=_blank style='color:#2F92EE;'>#比较分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63652, encryptionId=18ae6365278, topicName=比较分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Wed May 18 23:52:33 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194242, encodeId=b3fe1194242d7, content=<a href='/topic/show?id=36d313833c9' target=_blank style='color:#2F92EE;'>#PCI#</a><a href='/topic/show?id=77c33081e40' target=_blank style='color:#2F92EE;'>#冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13833, encryptionId=36d313833c9, topicName=PCI), TopicDto(id=30817, encryptionId=77c33081e40, topicName=冠心病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:57:15 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623534, encodeId=59b51623534dc, content=<a href='/topic/show?id=37de5691841' target=_blank style='color:#2F92EE;'>#搭桥手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56918, encryptionId=37de5691841, topicName=搭桥手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c320527759, createdName=stfoxst, createdTime=Fri Jan 14 23:52:33 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184021, encodeId=630b1184021ed, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8b5623723, createdName=ms6000000656440728, createdTime=Thu Jan 13 21:00:37 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183897, encodeId=d8e8118389e23, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a83e6464002, createdName=ms4000001897618690, createdTime=Thu Jan 13 15:22:13 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
    2022-01-13 ms6000000656440728

    不错啊

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1663988, encodeId=d1fa1663988b9, content=<a href='/topic/show?id=03a35691e2e' target=_blank style='color:#2F92EE;'>#搭桥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56917, encryptionId=03a35691e2e, topicName=搭桥)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=557f25711234, createdName=12498b3em16(暂无昵称), createdTime=Sat Sep 24 08:52:33 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1988407, encodeId=11ee198840ed3, content=<a href='/topic/show?id=18ae6365278' target=_blank style='color:#2F92EE;'>#比较分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63652, encryptionId=18ae6365278, topicName=比较分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Wed May 18 23:52:33 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194242, encodeId=b3fe1194242d7, content=<a href='/topic/show?id=36d313833c9' target=_blank style='color:#2F92EE;'>#PCI#</a><a href='/topic/show?id=77c33081e40' target=_blank style='color:#2F92EE;'>#冠心病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13833, encryptionId=36d313833c9, topicName=PCI), TopicDto(id=30817, encryptionId=77c33081e40, topicName=冠心病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:57:15 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623534, encodeId=59b51623534dc, content=<a href='/topic/show?id=37de5691841' target=_blank style='color:#2F92EE;'>#搭桥手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56918, encryptionId=37de5691841, topicName=搭桥手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7c320527759, createdName=stfoxst, createdTime=Fri Jan 14 23:52:33 CST 2022, time=2022-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184021, encodeId=630b1184021ed, content=不错啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd8b5623723, createdName=ms6000000656440728, createdTime=Thu Jan 13 21:00:37 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183897, encodeId=d8e8118389e23, content=11, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a83e6464002, createdName=ms4000001897618690, createdTime=Thu Jan 13 15:22:13 CST 2022, time=2022-01-13, status=1, ipAttribution=)]
    2022-01-13 ms4000001897618690

    11

    0

相关资讯

Frontiers:注意你的糖化!我国学者发现糖化升高影响冠心病支架植入结果!

斑块脆弱性的增加和更高的脂质变异性是不良心血管事件的原因。

NEJM:搭桥 or 支架?冠心病患者的选择因病情而异!

在三血管冠状动脉疾病患者中,就死亡、心肌梗死、中风或1年后重复血管治疗的发生率而言,FFR引导下的PCI并不劣于CABG。

NEJM:高出血风险患者PCI后双重抗血小板治疗

就净不良临床事件和主要不良心脏或大脑事件的发生情况而言,1个月的双重抗血小板治疗不劣于2个月以上的持续治疗;缩短治疗可使大出血或临床相关的非大出血发生率降低。

EHJ:我国学者:糖尿病合并冠心病患者PCI与CABG手术疗效死亡率相当!

心血管疾病(CVD)是糖尿病最主要的合并症,影响着近三分之一的患者。

Lancet:阜外医院:定量流量比指导的病变选择策略能明显改善PCI术后患者的临床结局

在接受PCI的患者中,与标准血管造影指导相比,QFR指导的病变选择策略改善了1年的临床结果。

营养不良小case?可使急性心梗PCI术后死亡风险升高6倍!

BMC Cardiovascular Disorders:营养状况对经皮冠状动脉介入治疗急性心肌梗死患者预后的影响